Biofrontera (BFRI) Total Current Liabilities (2020 - 2025)

Biofrontera's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $11.9 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 1.05% year-over-year to $11.9 million; the TTM figure through Dec 2025 stood at $11.9 million (down 1.05% YoY), while the FY2025 annual figure was $11.9 million, down 1.05% from the prior year.
• Total Current Liabilities was $11.9 million for Q4 2025 at Biofrontera, down from $12.6 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $29.1 million in Q3 2023 to a low of $9.3 million in Q2 2024.
• Historically, Total Current Liabilities has averaged $15.3 million across 5 years, with a median of $13.8 million in 2021.
• The sharpest annual moves came in 2021 and 2024: Total Current Liabilities soared 213.03% in 2021, then plunged 62.12% in 2024.
• A 5-year view of Total Current Liabilities shows it stood at $13.8 million in 2021, then soared by 51.01% to $20.9 million in 2022, then retreated by 13.43% to $18.1 million in 2023, then slumped by 33.54% to $12.0 million in 2024, then fell by 1.05% to $11.9 million in 2025.
• The last three Total Current Liabilities figures came in at $11.9 million (Q4 2025), $12.6 million (Q3 2025), and $19.7 million (Q2 2025), per Business Quant data.